These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8726514)

  • 1. Vaccination of chimpanzees against HIV-1.
    Girard M; Barré-Sinoussi F; van der Ryst E
    Antibiot Chemother (1971); 1996; 48():121-4. PubMed ID: 8726514
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization and challenge of chimpanzees with HIV-1.
    Fultz PN
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1517-9. PubMed ID: 1466994
    [No Abstract]   [Full Text] [Related]  

  • 3. CD8 T cell anti-HIV activity as a complementary protective mechanism in vaccinated chimpanzees.
    Leno M; Kowalski M; Robert-Guroff M
    AIDS; 2000 May; 14(7):893-4. PubMed ID: 10839598
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlates of protective immunity against HIV-1 infection in immunized chimpanzees.
    Murthy KK; Cobb EK; Rouse SR; Lunceford SM; Johnson DE; Galvan AR
    Immunol Lett; 1996 Jun; 51(1-2):121-4. PubMed ID: 8811355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HIV vaccine pipeline, from preclinical to phase III.
    Schultz AM; Bradac JA
    AIDS; 2001; 15 Suppl 5():S147-58. PubMed ID: 11816163
    [No Abstract]   [Full Text] [Related]  

  • 6. [HIV-1 vaccination--is there hope?].
    Speck RF; Brander C; Kündig TM
    Ther Umsch; 2005 Oct; 62(10):695-702. PubMed ID: 16277037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [AIDS vaccine].
    Sikorska EJ
    Pneumonol Alergol Pol; 1991; 59(3-4):146-52. PubMed ID: 1843911
    [No Abstract]   [Full Text] [Related]  

  • 8. Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial.
    Ugen KE; Boyer JD; Wang B; Bagarazzi M; Javadian A; Frost P; Merva MM; Agadjanyan MG; Nyland S; Williams WV; Coney L; Ciccarelli R; Weiner DB
    Vaccine; 1997 Jun; 15(8):927-30. PubMed ID: 9234550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of a vaccine against HIV: is this aim accomplishable?].
    Wagner R; Asbach B
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():36-9. PubMed ID: 23961653
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prospects for vaccine development against HIV infection].
    Kurth R; Binninger D; Ennen J; Denner J; Hartung S; Norley S
    Verh Dtsch Ges Inn Med; 1991; 97():394-402. PubMed ID: 1808921
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virus.
    Girard M; van der Ryst E; Barré-Sinoussi F; Nara P; Tartaglia J; Paoletti E; Blondeau C; Jennings M; Verrier F; Meignier B; Fultz PN
    Virology; 1997 May; 232(1):98-104. PubMed ID: 9185593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees.
    Bagarazzi ML; Boyer JD; Ugen KE; Javadian MA; Chattergoon M; Shah A; Bennett M; Ciccarelli R; Carrano R; Coney L; Weiner DB
    Vaccine; 1998 Nov; 16(19):1836-41. PubMed ID: 9795389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees.
    Bruck C; Thiriart C; Fabry L; Francotte M; Pala P; Van Opstal O; Culp J; Rosenberg M; De Wilde M; Heidt P; Heeney J
    Vaccine; 1994 Sep; 12(12):1141-8. PubMed ID: 7998425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology. Immune activation with HIV vaccines.
    Fauci AS; Marovich MA; Dieffenbach CW; Hunter E; Buchbinder SP
    Science; 2014 Apr; 344(6179):49-51. PubMed ID: 24700849
    [No Abstract]   [Full Text] [Related]  

  • 15. Mucosally-targeted HIV-1 vaccines.
    Wegmann F
    Hum Vaccin; 2011 Sep; 7(9):982-5. PubMed ID: 21892008
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV Vaccines: One Step Closer.
    Low MSY; Tarlinton D
    Trends Mol Med; 2017 Jan; 23(1):1-3. PubMed ID: 27889424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective mucosal immunity and HIV-1 mucosal vaccine strategy].
    Huang Y; Huang XG; Xu JQ
    Bing Du Xue Bao; 2009 Jul; 25(4):318-22. PubMed ID: 19769168
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV vaccine development: lessons learned to date.
    Putney SD
    Biotechnol Ther; 1991; 2(1-2):1-7. PubMed ID: 1726960
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.
    Boyer JD; Ugen KE; Wang B; Agadjanyan M; Gilbert L; Bagarazzi ML; Chattergoon M; Frost P; Javadian A; Williams WV; Refaeli Y; Ciccarelli RB; McCallus D; Coney L; Weiner DB
    Nat Med; 1997 May; 3(5):526-32. PubMed ID: 9142121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.
    Boyer JD; Cohen AD; Ugen KE; Edgeworth RL; Bennett M; Shah A; Schumann K; Nath B; Javadian A; Bagarazzi ML; Kim J; Weiner DB
    AIDS; 2000 Jul; 14(11):1515-22. PubMed ID: 10983638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.